Κυριακή 26 Ιουλίου 2020


What the physicians should know about mast cells, dendritic cells, urticaria and omalizumab during COVID‐19 or asymptomatic infections due to SARS‐CoV‐2?
ABSTRACT COVID‐19 pandemic presents several dermatological manifestations described in the present indexed literature, with around 700 cases reported until May 2020, some described as urticaria or urticarial rashes. Urticaria is constituted by evanescent erythematous‐edematous lesions (wheals and flare), which does not persist in the same site for more than 24‐48 hours and appears in other topographic localization, resolving without residual hyper pigmentation. During the SARS‐CoV‐2 infection, some...
Wiley: Dermatologic Therapy: Table of Contents
Sat Jul 25, 2020 18:47
Effectiveness of gromwell (Lithospermum erythrorhizon) oil in the treatment of toxic epidermal necrolysis in a patient with dermatomyositis
Wiley: Dermatologic Therapy: Table of Contents
Sat Jul 25, 2020 18:23
The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: a Spanish multicentre retrospective study
Abstract Introduction The objective of the study was to evaluate efficacy and safety of ixekizumab in psoriasis patients under clinical practice conditions. Material and methods Observational, retrospective, multicentre study that included patients with ixekizumab from March 2017 to March 2019. ≥ 90 % reduction in the Psoriasis Area and Severity Index (PASI 90) and absolute PASI < 2 were the parameters used to assess treatment response. Adverse events (AEs) were collected. Results...
Wiley: Dermatologic Therapy: Table of Contents
Sat Jul 25, 2020 18:13
Efficacy of Vismodegib in pigmented basal cell carcinoma: appearances are deceiving
Abstract Basal cell carcinoma (BCC) is the most common skin cancer in humans. Pigmented basal cell carcinoma (pBCC) is a rare variant of BCC. Vismodegib, was the first drug to be approved for the treatment of locally advanced (laBCCs) or metastatic basal cell carcinoma. The aim of this study was to evaluate the efficacy of Vismodegib in patients with pBCCs. We retrospectively analyzed patients receiving Vismodegib as treatment for laBCCs presenting also various pBCCs. After 6 months of treatment...
Wiley: Dermatologic Therapy: Table of Contents
Sat Jul 25, 2020 18:03
How to manage high risk asymptomatic COVID‐19 carriers; COVID‐19 poses a huge threat to public health and to dermatology specialty as well
Wiley: Dermatologic Therapy: Table of Contents
Sat Jul 25, 2020 13:19
Management of Patients with Behçet's Disease During the COVID‐19 Pandemic
Abstract Behçet's disease is a disease characterized by chronic inflammatory vasculitis. In the clinical symptoms of Behçet's disease, many immunosuppressive and immunomodulatory drugs are used. The suspicion that drugs used in chronic disease treatments such as Behçet's disease during pandemic will increase the risk of transmission of COVID‐19 disease, and that the disease may progress more lethally in these patients after the infection caused clinicians to worry. As far as we know, there is no...
Wiley: Dermatologic Therapy: Table of Contents
Sat Jul 25, 2020 13:10
Obstructive sleep apnea syndrome in patients with chronic idiopathic urticaria
Abstract Background Urticaria is a disease which progresses with itchy papules and plaques called urtica, obstructive sleep apnea syndrome (OSAS) is defined as daytime sleepiness and obstructive apnea and hypopnea attacks during sleep. In this study, we aimed to investigate the relationship between urticaria and OSAS. Materyel and methods Thirty one patients with chronic idiopathic urticaria were included in the study. . Body mass indexes (BMI) were calculated and polysomnography findings...
Wiley: Dermatologic Therapy: Table of Contents
Fri Jul 24, 2020 22:36
Social Awareness about Psoriasis: misconceptions, negative prejudices and discriminatory behaviour
Abstract Psoriasis patients experience negative attitudes and behaviors exhibited by people who have insufficient knowledge about psoriasis. In this study, the knowledge level of the society about psoriasis; people's attitudes toward such patients were investigated. A questionnaire that investigates the knowledge, attitudes and behaviors related to psoriasis according to age, gender and education levels was applied to the participants. About a quarter of participants in the study did not have any...
Wiley: Dermatologic Therapy: Table of Contents
Fri Jul 24, 2020 22:34
Emerging Rheumatologic Reactions with Th2 Blockade
Wiley: Dermatologic Therapy: Table of Contents
Fri Jul 24, 2020 21:03
Mycosis fungoides mimicking pigmented purpuric dermatosis
Wiley: Dermatologic Therapy: Table of Contents
Fri Jul 24, 2020 11:28
Network pharmacology‐based identification for therapeutic mechanisms of Dangguikushen pill in acne vulgaris
Abstract Background The Dangguikushen (DGKS) pill is a proprietary traditional Chinese medicine that has shown superior efficacy in the treatment of acne vulgaris for many years. Methods A network pharmacology‐based analysis was performed to explore the potential anti‐acne compounds, core therapeutic targets, and the main pathways, involved in the DGKS pill bioactivity. The matching results between the predicted targets of the DGKS pill and the well‐known targets of acne vulgaris were collected,...
Wiley: Dermatologic Therapy: Table of Contents
Fri Jul 24, 2020 11:25
Fish tank granuloma during tumor necrosis factor‐alpha inhibitor treatment: A case report and literature review
Wiley: Dermatologic Therapy: Table of Contents
Thu Jul 23, 2020 21:59
Lymecycline as a treatment option for dissecting cellulitis and folliculitis decalvans
Wiley: Dermatologic Therapy: Table of Contents
Thu Jul 23, 2020 20:19
Response to‐ Management of Leprosy patients in era of covid
Wiley: Dermatologic Therapy: Table of Contents
Thu Jul 23, 2020 20:15

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου